ORAL01.03: CheckMate 012: Safety and Efficacy of First-Line Nivolumab and Ipilimumab in Advanced NSCLC: Topic: Medical Oncology.
Journal Article (Journal Article)
Full Text
Duke Authors
Cited Authors
- Antonia, SJ; Gettinger, SN; Goldman, J; Brahmer, J; Borghaei, H; Chow, LQ; Ready, NE; Gerber, DE; Juergens, R; Shepherd, F; Laurie, SA; Young, T; Geese, WJ; Agrawal, S; Li, X; Hellmann, MD
Published Date
- November 2016
Published In
Volume / Issue
- 11 / 11S
Start / End Page
- S250 - S251
PubMed ID
- 27969442
Electronic International Standard Serial Number (EISSN)
- 1556-1380
Digital Object Identifier (DOI)
- 10.1016/j.jtho.2016.09.008
Language
- eng
Conference Location
- United States